Kazia Therapeutics Ltd Sponsored ADR
(NASDAQ : KZIA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.33%89.831.3%$814.68m
AMGNAmgen Inc.
1.30%187.911.2%$637.16m
GILDGilead Sciences, Inc.
0.49%65.870.9%$484.65m
BIIBBiogen Inc.
0.69%323.401.3%$430.41m
ILMNIllumina, Inc.
1.41%301.073.5%$315.75m
REGNRegeneron Pharmaceuticals, Inc.
0.96%422.632.6%$292.96m
VRTXVertex Pharmaceuticals Incorporated
0.98%184.851.9%$256.06m
ALXNAlexion Pharmaceuticals, Inc.
0.93%128.742.0%$221.73m
SRPTSarepta Therapeutics, Inc.
2.22%139.5715.4%$155.71m
AAgilent Technologies, Inc.
0.06%77.941.6%$150.90m
EXASExact Sciences Corporation
9.03%90.8025.3%$144.22m
INCYIncyte Corporation
1.18%84.312.5%$113.25m
ARRYArray BioPharma Inc.
3.76%23.568.2%$112.05m
EXELExelixis, Inc.
0.90%21.416.4%$82.80m
NBIXNeurocrine Biosciences, Inc.
1.57%78.525.1%$78.43m

Company Profile

Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.